Anthem Biosciences Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹769.9Market Cap
₹ 43,360 Cr.Stock P/E
73.1ROE
22.3 %RSI
48.01Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Incorporated in 2006, Anthem Biosciences Ltd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]
Anthem Biosciences Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Anthem Biosciences Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Anthem Biosciences Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 769.9 |
| RSI (14) | 48.01 |
| 50 DMA | 768.88 |
| 200 DMA | 706.27 |
| Trend | Bullish |
| A/D Rating | C |
| RS Rating | 50 |
| EPS Rating | 50 |
| TI65 | 1.01 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Anthem Biosciences Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹789.14 |
| R2 | ₹784.27 |
| R1 | ₹777.09 |
| PP | ₹772.22 |
| S1 | ₹765.04 |
| S2 | ₹760.17 |
| S3 | ₹752.99 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 43,360 Cr. |
| Current Price | ₹ 770 |
| High / Low | ₹ 874 / 579 |
| Stock P/E | 73.1 |
| Book Value | ₹ 54.2 |
| Dividend Yield | 0.26 % |
| ROCE | 30.4 % |
| ROE | 22.3 % |
| Face Value | ₹ 2.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2024 | 339 | 82 | 36% |
| Sep 2024 | 525 | 162 | 37% |
| Dec 2024 | 498 | 124 | 32% |
| Mar 2025 | 483 | 83 | 40% |
| Jun 2025 | 540 | 136 | 35% |
| Sep 2025 | 550 | 173 | 40% |
| Dec 2025 | 423 | 93 | 37% |
| Mar 2026 | 611 | 190 | 44% |
| Jun 2026 | 418 | 120 | 36% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 74.67% |
| FIIs | 1.28% |
| DIIs | 11.55% |
| Public | 12.48% |
| No. of Shareholders | 1,80,220 |
Pros and Cons
Pros
- Healthy return on equity of 22.3% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (768.88).
Cons
- Valuation metrics appear elevated with a trailing P/E of 73.1, demanding high performance requirements.
Related NSE Stocks
India Cements Ltd.
View Share Price Analysis →Castrol India Ltd.
View Share Price Analysis →ICICI Prudential Asset Management Company Ltd.
View Share Price Analysis →Syrma SGS Technology Ltd.
View Share Price Analysis →Cartrade Tech Ltd.
View Share Price Analysis →Poly Medicure Ltd.
View Share Price Analysis →Aavas Financiers Ltd.
View Share Price Analysis →Gabriel India Ltd.
View Share Price Analysis →Wipro Ltd.
View Share Price Analysis →Honeywell Automation India Ltd.
View Share Price Analysis →Linde India Ltd.
View Share Price Analysis →Prime Focus Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Anthem Biosciences Ltd share?
Based on the latest closing data, the technical momentum for Anthem Biosciences Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 48.01, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (768.88) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Anthem Biosciences Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Anthem Biosciences Ltd today centers at a Pivot Point (PP) of ₹772.22. Upside resistance challenges are calculated at R1: ₹777.09, R2: ₹784.27, and R3: ₹789.14. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹765.04, S2: ₹760.17, and S3: ₹752.99.
How does the fundamental ROE and P/E ratio look for Anthem Biosciences Ltd?
Anthem Biosciences Ltd is currently trading with a valuation metrics context of a Stock P/E of 73.1, against a core structural efficiency Return on Equity (ROE) standing at 22.3 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 50, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Anthem Biosciences Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Symmetric Breakout Squeeze Play (Neutral / Monitor Closely). Anthem Biosciences ... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of C, a Relative Strength (RS) ranking of 50, and long-term trend backing from the TI65 indicator (Neutral pattern).